SOUTH SAN FRANCISCO, Calif. & LEXINGTON, Mass.–(BUSINESS WIRE)–Maze Therapeutics, a company focused on translating genetic insights into new medicines, and Alloy Therapeutics, a company developing platforms and services to enable drug discovery, today announced the formation of Broadwing Bio to develop targeted antibody therapies for the treatment of ophthalmic diseases.
Read more here.
![[Replay Technologies in The Jerusalem Post] Israeli technology let Super Bowl fans see plays at face mask level](https://blog.ourcrowd.net/wp-content/themes/Extra/images/post-format-thumb-text.svg)
